LINKS
contact
SOCIAL
  • Black LinkedIn Icon
  • Black Facebook Icon
  • Black Twitter Icon
  • Black Google+ Icon

info@bionode.net

vox: +1 (317) 292-7686

7987 clearwater pkwy

indianapolis, in 46240 usa

© 2023 by DATO. Proudly created with Wix.com

neuromodulation

01 / the next big wave in medicine ...

set to revolutionize healthcare, neuromodulation  offers a higher degree of control over biological functions and disease states than pharmaceuticals ... while avoiding unwanted side effects. bionode delivers electroceuticals.

02 / proprietary technology ...

bionode has secured rights to a rich intellectual property portfolio of technologies, originally developed under the direction of Prof. Irazoqui at the Center for Implantable Devices (CID) at Purdue University's Weldon School of BioMedical Engineering.

glaucoma is silent, progressive, and frequently results in loss of vision and blindness as the optic nerve degenerates from elevated intra-ocular pressure (IOP). bionode  has developed a device for the treatment of glaucoma, using electrical impulses to normalize IOP.

for the treatment of

elevated intra-ocular pressure

in glaucoma

glaucoma

glaucoma is a leading cause of blindness in the US and worldwide.

 the power

imperceptible electrical impulses are generated in a unique waveform by the coils in the special 'glasses' and wirelessly delivered to the eye (experimental prototype pictured).  

your vision

contact lenses with embedded

gold traces receive and focus

the impulses onto the eye.

contact info

for further information

 
 
 
 
 

bionode 

      the future is here.

its just not widely distributed yet.

william gibson

Pedro Irazoqui, Ph.D.
CoFounder& CTO 
pip@bionode.net
Murray I. Firestone, Ph.D.
CoFounder & CEO
mif@bionode.net

bionode in the news ...